Cargando…
Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection
INTRODUCTION: COVID-19 infection has been associated with right ventricular (RV) dysfunction and poor prognosis. This association is thought to be due to either a direct effect of COVID-19 infection on the myocardium or indirect damage to the lung parenchyma or vasculature. Limited echocardiography...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090114/ http://dx.doi.org/10.1016/j.cardfail.2022.10.419 |
_version_ | 1785022902933913600 |
---|---|
author | Rodriguez, Beatriz P Rivera Peralta, Ramon A Romano Andrade-Bucknor, Sharon Yan, Crystal Olarte, Neal Kaur, Sukhpreet |
author_facet | Rodriguez, Beatriz P Rivera Peralta, Ramon A Romano Andrade-Bucknor, Sharon Yan, Crystal Olarte, Neal Kaur, Sukhpreet |
author_sort | Rodriguez, Beatriz P Rivera |
collection | PubMed |
description | INTRODUCTION: COVID-19 infection has been associated with right ventricular (RV) dysfunction and poor prognosis. This association is thought to be due to either a direct effect of COVID-19 infection on the myocardium or indirect damage to the lung parenchyma or vasculature. Limited echocardiography protocols for operator protection against COVID-19 has made the evaluation of the RV challenging. The purpose of this study is to evaluate if RV dysfunction by qualitative assessment can be used to predict all-cause mortality. METHODS: This is a single-center retrospective analysis from March 2020 to August 2021. Patients who were older than 18 years old, hospitalized with a positive RT-PCR for COVID-19, and had an echocardiogram while inpatient were included in the study. RV parameters, including RV dilation and dysfunction, were obtained by qualitative assessment. Data analysis was performed with STATA and SPSS. RESULTS: A total of 223 patients were included in the analysis. 59.6% were male with a mean age of 64.3 years (SD +/- 16). 67.7% were Hispanic, 11.7% were non-Hispanic White, and 20.6% were Black. Severe COVID-19 infection requiring intensive care unit level of care made up 54.7% of cases (n=122) and the mortality rate was 27.8% (n=62). RV dysfunction and dilation was present in 13.5% (n=28) and 15.2% (n=33) of patients, respectively and occurred more often in patients with severe COVID-19 infection (p<0.01). Logistic binomial correlation showed an exponential increase in the probability of mortality related to RV dysfunction (OR 2.03, p=0.270; graph 1) and a mild decrease in mortality in patients with RV dilation (OR 0.88, p=0.794). However, both associations were not statistically significant. CONCLUSION: RV dysfunction by qualitative assessment could be a potential marker of mortality in patients with COVID-19 infection. The association may be stronger in studies with more power. Interestingly, RV dilation was associated with a mild decrease in mortality in this patient population; however, this may be a biased result due to the small sample size. |
format | Online Article Text |
id | pubmed-10090114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100901142023-04-12 Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection Rodriguez, Beatriz P Rivera Peralta, Ramon A Romano Andrade-Bucknor, Sharon Yan, Crystal Olarte, Neal Kaur, Sukhpreet J Card Fail 412 INTRODUCTION: COVID-19 infection has been associated with right ventricular (RV) dysfunction and poor prognosis. This association is thought to be due to either a direct effect of COVID-19 infection on the myocardium or indirect damage to the lung parenchyma or vasculature. Limited echocardiography protocols for operator protection against COVID-19 has made the evaluation of the RV challenging. The purpose of this study is to evaluate if RV dysfunction by qualitative assessment can be used to predict all-cause mortality. METHODS: This is a single-center retrospective analysis from March 2020 to August 2021. Patients who were older than 18 years old, hospitalized with a positive RT-PCR for COVID-19, and had an echocardiogram while inpatient were included in the study. RV parameters, including RV dilation and dysfunction, were obtained by qualitative assessment. Data analysis was performed with STATA and SPSS. RESULTS: A total of 223 patients were included in the analysis. 59.6% were male with a mean age of 64.3 years (SD +/- 16). 67.7% were Hispanic, 11.7% were non-Hispanic White, and 20.6% were Black. Severe COVID-19 infection requiring intensive care unit level of care made up 54.7% of cases (n=122) and the mortality rate was 27.8% (n=62). RV dysfunction and dilation was present in 13.5% (n=28) and 15.2% (n=33) of patients, respectively and occurred more often in patients with severe COVID-19 infection (p<0.01). Logistic binomial correlation showed an exponential increase in the probability of mortality related to RV dysfunction (OR 2.03, p=0.270; graph 1) and a mild decrease in mortality in patients with RV dilation (OR 0.88, p=0.794). However, both associations were not statistically significant. CONCLUSION: RV dysfunction by qualitative assessment could be a potential marker of mortality in patients with COVID-19 infection. The association may be stronger in studies with more power. Interestingly, RV dilation was associated with a mild decrease in mortality in this patient population; however, this may be a biased result due to the small sample size. Published by Elsevier Inc. 2023-04 2023-04-12 /pmc/articles/PMC10090114/ http://dx.doi.org/10.1016/j.cardfail.2022.10.419 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 412 Rodriguez, Beatriz P Rivera Peralta, Ramon A Romano Andrade-Bucknor, Sharon Yan, Crystal Olarte, Neal Kaur, Sukhpreet Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection |
title | Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection |
title_full | Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection |
title_fullStr | Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection |
title_full_unstemmed | Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection |
title_short | Right Ventricular Dysfunction: Predictor Of Mortality In COVID-19 Infection |
title_sort | right ventricular dysfunction: predictor of mortality in covid-19 infection |
topic | 412 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090114/ http://dx.doi.org/10.1016/j.cardfail.2022.10.419 |
work_keys_str_mv | AT rodriguezbeatrizprivera rightventriculardysfunctionpredictorofmortalityincovid19infection AT peraltaramonaromano rightventriculardysfunctionpredictorofmortalityincovid19infection AT andradebucknorsharon rightventriculardysfunctionpredictorofmortalityincovid19infection AT yancrystal rightventriculardysfunctionpredictorofmortalityincovid19infection AT olarteneal rightventriculardysfunctionpredictorofmortalityincovid19infection AT kaursukhpreet rightventriculardysfunctionpredictorofmortalityincovid19infection |